On January 20, 2023, Pangenomic Health Inc. closed the transaction. The company has issued total of 3,415,000 units for gross proceeds of CAD 512,250 in oversubscribed transaction. The company has issued 2,081,667 units for for gross proceeds of CAD 312,500 in its second and final tranche.

The company has paid registered broker a cash fee of CAD 750. All securities issuable in connection with the final tranche are subject to a statutory hold period under applicable securities laws of four months and one day from the date of issue.